Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amobarbital for Myocardial Protection in Cardiac Surgery
NCT06757868Completed
- Sponsor
- Tongji Hospital
- Start
- Feb 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of amobarbital in cardiopulmonary bypass (CPB) (2 arms), sponsored by Tongji Hospital. Primary endpoint: Cardiac recurrence time. Started Feb 2025; status: completed.
02
Drugs
amobarbital
03
Conditions
cardiopulmonary bypass (CPB)
Beyond the preview
Go deeper on NCT06757868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06757868.